Anika Therapeutics (ANIK) Competitors $16.44 +0.21 (+1.29%) (As of 12:14 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ANIK vs. CERS, OSUR, UTMD, WST, COO, ALGN, MMSI, HAE, ICUI, and XRAYShould you be buying Anika Therapeutics stock or one of its competitors? The main competitors of Anika Therapeutics include Cerus (CERS), OraSure Technologies (OSUR), Utah Medical Products (UTMD), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), ICU Medical (ICUI), and DENTSPLY SIRONA (XRAY). These companies are all part of the "health care supplies" industry. Anika Therapeutics vs. Cerus OraSure Technologies Utah Medical Products West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical DENTSPLY SIRONA Cerus (NASDAQ:CERS) and Anika Therapeutics (NASDAQ:ANIK) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, community ranking, risk, analyst recommendations, earnings and institutional ownership. Do analysts rate CERS or ANIK? Cerus currently has a consensus target price of $3.63, suggesting a potential upside of 125.86%. Anika Therapeutics has a consensus target price of $24.50, suggesting a potential upside of 47.77%. Given Cerus' stronger consensus rating and higher probable upside, equities research analysts plainly believe Cerus is more favorable than Anika Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75Anika Therapeutics 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has higher earnings and valuation, CERS or ANIK? Cerus has higher revenue and earnings than Anika Therapeutics. Cerus is trading at a lower price-to-earnings ratio than Anika Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$176.23M1.69-$37.49M-$0.11-14.59Anika Therapeutics$164.17M1.48-$82.67M-$6.65-2.49 Does the media refer more to CERS or ANIK? In the previous week, Anika Therapeutics had 1 more articles in the media than Cerus. MarketBeat recorded 1 mentions for Anika Therapeutics and 0 mentions for Cerus. Cerus' average media sentiment score of 0.60 beat Anika Therapeutics' score of 0.00 indicating that Cerus is being referred to more favorably in the media. Company Overall Sentiment Cerus Positive Anika Therapeutics Neutral Is CERS or ANIK more profitable? Cerus has a net margin of -11.19% compared to Anika Therapeutics' net margin of -59.40%. Anika Therapeutics' return on equity of -2.22% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-11.19% -37.90% -10.35% Anika Therapeutics -59.40%-2.22%-1.75% Which has more risk & volatility, CERS or ANIK? Cerus has a beta of 1.24, indicating that its stock price is 24% more volatile than the S&P 500. Comparatively, Anika Therapeutics has a beta of 0.89, indicating that its stock price is 11% less volatile than the S&P 500. Do insiders & institutionals have more ownership in CERS or ANIK? 78.4% of Cerus shares are owned by institutional investors. Comparatively, 91.5% of Anika Therapeutics shares are owned by institutional investors. 3.4% of Cerus shares are owned by insiders. Comparatively, 7.9% of Anika Therapeutics shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the MarketBeat Community prefer CERS or ANIK? Cerus received 266 more outperform votes than Anika Therapeutics when rated by MarketBeat users. Likewise, 72.30% of users gave Cerus an outperform vote while only 64.33% of users gave Anika Therapeutics an outperform vote. CompanyUnderperformOutperformCerusOutperform Votes56972.30% Underperform Votes21827.70% Anika TherapeuticsOutperform Votes30364.33% Underperform Votes16835.67% SummaryCerus beats Anika Therapeutics on 12 of the 18 factors compared between the two stocks. Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Get Anika Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIK and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ANIK vs. The Competition Export to ExcelMetricAnika TherapeuticsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$242.83M$4.35B$5.21B$9.23BDividend YieldN/A44.59%5.12%4.30%P/E Ratio-2.4924.9587.6917.23Price / Sales1.4853.121,166.33121.51Price / Cash3.6343.4043.2337.84Price / Book1.147.114.814.92Net Income-$82.67M$13.64M$120.46M$225.43M7 Day Performance-0.24%0.12%-0.85%0.61%1 Month Performance-2.30%-0.80%15.42%2.23%1 Year Performance-28.84%39.35%29.98%16.55% Anika Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ANIKAnika Therapeutics3.6972 of 5 stars$16.44+1.3%$24.50+49.0%-30.3%$240.78M$164.17M-2.47357CERSCerus2.8294 of 5 stars$1.61+1.9%$3.63+125.2%-29.8%$299.00M$176.23M-14.64625OSUROraSure Technologies4.3757 of 5 stars$3.65+0.3%$5.50+50.7%-56.3%$272.27M$224.26M24.33638UTMDUtah Medical Products2.0461 of 5 stars$61.02flatN/A-28.3%$206.98M$44.08M14.29180WSTWest Pharmaceutical Services4.9646 of 5 stars$328.80-0.8%$437.75+33.1%-7.1%$23.81B$2.88B48.7810,600Positive NewsCOOCooper Companies3.4957 of 5 stars$92.38-1.1%$117.00+26.7%-0.9%$18.44B$3.90B47.3715,000ALGNAlign Technology4.9033 of 5 stars$207.09-1.9%$271.20+31.0%-23.7%$15.46B$3.96B35.3421,610MMSIMerit Medical Systems4.423 of 5 stars$97.48-0.8%$105.60+8.3%+29.1%$5.68B$1.33B47.786,950Analyst ForecastHAEHaemonetics4.5978 of 5 stars$76.21+1.0%$108.78+42.7%-12.3%$3.83B$1.36B31.623,657ICUIICU Medical4.6656 of 5 stars$153.84-1.9%$199.67+29.8%+57.9%$3.77B$2.34B-33.6614,000Positive NewsXRAYDENTSPLY SIRONA4.8937 of 5 stars$18.77+0.4%$27.91+48.7%-46.2%$3.73B$3.90B-9.0715,000 Related Companies and Tools Related Companies Cerus Alternatives OraSure Technologies Alternatives Utah Medical Products Alternatives West Pharmaceutical Services Alternatives Cooper Companies Alternatives Align Technology Alternatives Merit Medical Systems Alternatives Haemonetics Alternatives ICU Medical Alternatives DENTSPLY SIRONA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ANIK) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredA.I. Trading System Helps Some Traders Pocket $1,100 per DAY!What if I told you 60 seconds a day could completely change your life? This AI-powered trading syst...Prosper Trading Academy | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredWall St. Icon: “If you wait on this, it will already be too late”If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anika Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anika Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
